Showing 1 - 1 results of 1 for search 'Vijay Yerroju', query time: 0.02s
Refine Results
-
1
A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants by Subhash Thuluva, SubbaReddy Gunneri, Kishore Turaga, Rammohan Reddy Mogulla, Vijay Yerroju, Kalyankumar Peta, Pothakamuri Venkata Suneetha, Ramesh V. Matur
Published 2023-12-01
Article